Acurx Pharmaceuticals Inc
ACXP0.295USD
-0.012-3.94%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
USD0.000Pre-mercado (ET)
6.61MCap. mercado
PérdidaP/E TTM
Acurx Pharmaceuticals Inc
0.295
-0.012-3.94%
Trimestral
Trimestral+Anual
Trimestral
Anual
YOY
Ocultar filas en blanco
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Gastos operativos
-50.91%2.15M
-45.61%2.78M
-9.42%2.82M
19.64%4.12M
50.81%4.38M
56.86%5.11M
-12.05%3.11M
31.47%3.45M
8.72%2.90M
24.11%3.26M
-23.71%3.54M
-35.62%2.62M
81.11%2.67M
140.35%2.63M
253.14%4.64M
345.67%4.07M
15.26%1.47M
--1.09M
--1.31M
--913.36K
--1.28M
Gastos de I+D
-61.49%598.80K
-57.53%825.06K
-11.18%1.20M
5.14%1.83M
53.12%1.56M
35.60%1.94M
-15.21%1.35M
90.46%1.74M
24.02%1.02M
100.03%1.43M
41.18%1.59M
858.93%911.69K
790.99%818.89K
56.54%716.22K
70.76%1.13M
-76.28%95.07K
-86.58%91.91K
--457.53K
--659.98K
--400.74K
--684.73K
Depreciación, agotamiento y amortización
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
Beneficios operativos
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
35.62%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-345.67%-4.07M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ingresos netos por intereses no operativos (gastos)
Ingresos especiales (gastos)
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--66.50K
--0.00
----
--0.00
--0.00
----
Ingresos antes de impuestos
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ingresos después de impuestos
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ingresos netos de operaciones continuas
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ingresos netos atribuibles a intereses controladores
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ingresos netos atribuibles a accionistas comunes
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Ganancias básicas por acción
62.10%-0.11
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
Ganancias diluidas por acción
62.10%-0.11
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
Dividendo por acción
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Unidad monetaria
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Opiniones de evaluación
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI